Jamali’s study showed that the expression of LAMP2 was significantly reduced in prostate cancer tissue and could trigger lysosomal membrane permeability, sensitizing cancer cells to lysosomal pathway mediated death. The gene discussed is LAMP2; the disease is cancer.